Alzheimer’s game-changing drug may be available for patients from next year, reveals expert

One of the world's leading experts has predicted that patients could receive the revolutionary Alzheimer's treatment as early as next year. However, scientists have cautioned that if the medication gets regulatory approval, dementia services will ...

Agencies
Lecanemab, a drug, has been demonstrated during clinical trials to clear the brain's harmful amyloid protein and postpone the onset of Alzheimer's symptoms, making it the first treatment in the world to slow brain aging. In a Phase 3 trial, the results released in September, the monoclonal antibody therapy demonstrated promising results.

A study involving 1,795 patients with early-stage Alzheimer's disease occurred in the US, Japan, Europe, and China. According to the product's makers, Tokyo-based Eisa and US company Biogen, the rate of cognitive decline was reduced by 27% after 18 months compared to a placebo.

All You Need To Know About Alzheimer’s Disease
1/10

Alzheimer’s is a type of progressive neurologic disorder that causes the brain to shrink and brain cells to die. It is a condition that destroys memory and other important mental functions.

Alzheimer’s is a type of progressive neurologic disorder that causes the brain to shrink and brain cells to die. It is a condition that destroys memory and other important mental functions.

Alzheimer’s is a type of progressive neurologic disorder that causes the brain to shrink and brain cells to die. It is a condition that destroys memory and other important mental functions.

Alzheimer’s is a type of progressive neurologic disorder that causes the brain to shrink and brain cells to die. It is a condition that destroys memory and other important mental functions.

According to the World Health Organization (WHO), Alzheimer’s disease is one of the most common causes of dementia, which starts reducing a person's ability to function independently.

According to the World Health Organization (WHO), Alzheimer’s disease is one of the most common causes of dementia, which starts reducing a person's ability to function independently.

According to the Centre for Disease Control, approximately 5.8 million people in the US over the age of 65 suffer from Alzheimer’s. In India, the number of Alzheimer's patients is expected to increase from 7 million 11.4 million by 2025.

According to the Centre for Disease Control, approximately 5.8 million people in the US over the age of 65 suffer from Alzheimer’s. In India, the number of Alzheimer's patients is expected to increas..
Read More

As Alzheimer’s causes the brain to atrophy, early signs of this condition include forgetting recent events and conversations. With time, Alzheimer’s can lead to severe memory impairments.

As Alzheimer’s causes the brain to atrophy, early signs of this condition include forgetting recent events and conversations. With time, Alzheimer’s can lead to severe memory impairments.

Besides memory loss, other symptoms of this condition include poor decision-making abilities, difficulty in getting the right word, asking questions repeatedly, etc.

Besides memory loss, other symptoms of this condition include poor decision-making abilities, difficulty in getting the right word, asking questions repeatedly, etc.

If you think that your memory is getting weak or you find it difficult to complete your daily tasks such as walking, eating and sleeping, then it is time for you to book an appointment with the doctor.

If you think that your memory is getting weak or you find it difficult to complete your daily tasks such as walking, eating and sleeping, then it is time for you to book an appointment with the docto..
Read More

Though there is no cure for Alzheimer’s in medical science, it is said that certain medicines and therapies can temporarily reduce the symptoms and slow the condition from worsening.

Though there is no cure for Alzheimer’s in medical science, it is said that certain medicines and therapies can temporarily reduce the symptoms and slow the condition from worsening.

A study conducted by the University of Waterloo has shown that music may reduce agitation and improve behavioural issues common in the middle stages of Alzheimer’s disease.

A study conducted by the University of Waterloo has shown that music may reduce agitation and improve behavioural issues common in the middle stages of Alzheimer’s disease.

Foods that help boost memory are good for your brain health, and are highly recommended for Alzheimer’s patients. Examples are leafy green vegetables, whole grains, berries and high-fibre foods.

Foods that help boost memory are good for your brain health, and are highly recommended for Alzheimer’s patients. Examples are leafy green vegetables, whole grains, berries and high-fibre foods.


A scale that evaluated memory, orientation, judgment, problem-solving, community affairs, the home, hobbies, and personal care was used to quantify these effects. Brain swelling was one of the side effects noted during the study, occurring at a rate of 12 points 5 percent for patients taking Lecanemab as opposed to 1 point 7 in the placebo group. Researchers hailed the discovery as an essential step forward in the ongoing fight against dementia. Millions of patients in the UK currently dealing with neurodegenerative disease may benefit from this treatment even though it is not a cure.

FAQ:

  1. What is the drug used for the clinical trial of Alzheimer's?
    Lecanemab.
  2. What is the common side effect found in this drug trial of Alzheimer's?
    Brain swelling, at a rate of 12 points 5 percent for patients taking Lecanemab versus 1 point 7 in the placebo group.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › UK News › Alzheimer’s game-changing drug may be available for patients from next year, reveals expert
Text Size:AAA
Success
This article has been saved

*

+